AstraZeneca Profit Falls on Generic Competition

Feb. 6 (Bloomberg) -- AstraZeneca said fourth-quarter profit fell as sales of its best-selling medicines and growth in emerging markets failed to compensate for increasing generic competition. Anna Edwards reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

China's Big Plans for the Robot Industry
03:02 - Beijing is seeing robotics as a stepping stone to a broader strategic goal: dominating emerging markets for artificial intelligence, driverless vehicles and digitally-connected appliances and homes. Bloomberg's Brian Bremner reports on "Bloomberg Markets: Asia." (Source: Bloomberg)
  • Chinese Regulators Eye Entrusted Investments
  • Amundi's Ameli-Renani Sees Value in Mexico
  • Loop Capital's Jim Reynolds on Infrastructure Investment